Daneshvar Medicine

Daneshvar Medicine

The effect of Boswellia serrata on blood glucose, insulin level and insulin resistance in type 2 diabetic patients

Authors
Akram Ahangarpour
Ali Akbari Fatemeh Ramezani
Hamid Heidari
Mostafa Pakmehr
Hajeye Shahbazian
Iraj Ahmadi
Zahra Mombeini
Babadi Hajani Mehrangiz
Abstract
 Background and Objective:
Type 2 diabetes mellitus is characterized by a progressive decline in insulin
action. Boswellia serrata administration during diabetes exerts
beneficial effects in diabetic rats. The purpose of this study was to assess
the effect of Boswellia serrata on blood glucose, insulin,
insulin resistance index in type 2 diabetes patients.   Materials and Methods: This
clinical trial study was done on sixty patients, males and females in the age
range of 30-48 years with type 2 diabetes. The patients were divided into 2
groups: 1. control group, 2. test group. Test group received Boswellia
serrata (300 mg, three times daily for 6 weeks، chewing and packaged form) and control group received oral
agents alone. Before and after 6-week treatment, blood samples were collected,
Plasma was separated and frizzed at -20oC until measurement. The
insulin levels and fasting blood glucose were measured and insulin resistance index was also calculated.   Results: The 6-week
administration of Boswellia serrata significantly decreased blood
glucose (173.71±10 vs 147.57±8 mg/dl, P < /span>
Keywords
Boswellia serrata
Blood glucose
Insulin
Insulin resistance
Daneshvar Medicine
Volume 20, Issue 6 - Serial Number 103
January and February 2013
Pages 11-18